Stockreport

Tiziana Life Sciences Advances with Promising Drug Trials [Yahoo! Finance]

Tiziana Life Sciences Ltd - Common Shares  (TLSA) 
PDF Tiziana Life Sciences has reported promising progress in its lead programs targeting neurodegenerative and autoimmune diseases, particularly with its drug Foralumab. En [Read more]